Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2011

01-06-2011 | Preclinical study

Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells

Authors: Yuehan Wu, Xun Guo, Yekaterina Brandt, Helen J. Hathaway, Rebecca S. Hartley

Published in: Breast Cancer Research and Treatment | Issue 2/2011

Login to get access

Abstract

The behavior of breast epithelial cells is influenced by their microenvironment which includes stromal cells and extracellular matrix (ECM). During cancer progression, the tissue microenvironment fails to control proliferation and differentiation, resulting in uncontrolled growth and invasion. Upon invasion, the ECM encountered by breast cancer cells changes from primarily laminin and collagen IV to primarily collagen I. We show here that culturing invasive breast cancer cells in 3-dimensional (3D) collagen I inhibits proliferation through direct regulation of cyclin E1, a G1/S regulator that is overexpressed in breast cancer. When the breast cancer cell line MDA-MB-231 was cultured within 3D collagen I gels, the G1/S transition was inhibited as compared to cells cultured on conventional 2D collagen or plastic dishes. Cells in 3D collagen downregulated cyclin E1 protein and mRNA, with no change in cyclin D1 level. Cyclin D1 was primarily cytoplasmic in 3D cultures, and this was accompanied by decreased phosphorylation of Rb, a nuclear target for both cyclin E1- and cyclin D1-associated kinases. Positive regulators of cyclin E1 expression, the transcription factor c-Myc and cold-inducible RNA binding protein (CIRP), were decreased in 3D collagen cultures, while the collagen I receptor β1 integrin was greatly increased. Inhibition of β1 integrin function rescued proliferation and cyclin E1 expression as well as c-Myc expression and Rb phosphorylation, but cyclin D1 remained cytoplasmic. We conclude that cyclin E1 is repressed independent of effects on cyclin D1 in a 3D collagen environment and dependent on β1 integrin interaction with collagen I, reducing proliferation of invasive breast cancer cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Duffy MJ, Crown J (2008) A personalized approach to cancer treatment: how biomarkers can help. Clin Chem 54:1770–1779PubMedCrossRef Duffy MJ, Crown J (2008) A personalized approach to cancer treatment: how biomarkers can help. Clin Chem 54:1770–1779PubMedCrossRef
2.
go back to reference Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, Hortobagyi GN, Yu D (2009) Breast cancer metastasis: challenges and opportunities. Cancer Res 69:4951–4953PubMedCrossRef Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, Hortobagyi GN, Yu D (2009) Breast cancer metastasis: challenges and opportunities. Cancer Res 69:4951–4953PubMedCrossRef
3.
go back to reference Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P (2003) Cyclin E ablation in the mouse. Cell 114:431–443PubMedCrossRef Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P (2003) Cyclin E ablation in the mouse. Cell 114:431–443PubMedCrossRef
4.
go back to reference Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699–2711PubMedCrossRef Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699–2711PubMedCrossRef
5.
go back to reference Butt AJ, McNeil CM, Musgrove EA, Sutherland RL (2005) Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer 12(Suppl 1):S47–S59. doi:10.1677/erc.1.00993 Butt AJ, McNeil CM, Musgrove EA, Sutherland RL (2005) Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer 12(Suppl 1):S47–S59. doi:10.​1677/​erc.​1.​00993
6.
go back to reference Keyomarsi K, O’Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380–385PubMed Keyomarsi K, O’Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380–385PubMed
7.
go back to reference Sieuwerts AM, Look MP, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, de Weerd V, Portengen H, Klijn JG, Foekens JA (2006) Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clin Cancer Res 12:3319–3328. doi:10.1158/1078-0432.CCR-06-0225 PubMedCrossRef Sieuwerts AM, Look MP, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, de Weerd V, Portengen H, Klijn JG, Foekens JA (2006) Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clin Cancer Res 12:3319–3328. doi:10.​1158/​1078-0432.​CCR-06-0225 PubMedCrossRef
8.
go back to reference Potemski P, Kusinska R, Pasz-Walczak G, Piekarski JH, Watala C, Pluciennik E, Bednarek AK, Kordek R (2009) Prognostic relevance of cyclin E expression in operable breast cancer. Med Sci Monit 15:MT34–MT40 Potemski P, Kusinska R, Pasz-Walczak G, Piekarski JH, Watala C, Pluciennik E, Bednarek AK, Kordek R (2009) Prognostic relevance of cyclin E expression in operable breast cancer. Med Sci Monit 15:MT34–MT40
9.
go back to reference Henriet P, Zhong ZD, Brooks PC, Weinberg KI, DeClerck YA (2000) Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc Natl Acad Sci USA 97:10026–10031PubMedCrossRef Henriet P, Zhong ZD, Brooks PC, Weinberg KI, DeClerck YA (2000) Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc Natl Acad Sci USA 97:10026–10031PubMedCrossRef
10.
go back to reference Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R (1996) Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87:1069–1078PubMedCrossRef Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R (1996) Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87:1069–1078PubMedCrossRef
11.
go back to reference Cho MK, Suh SH, Lee CH, Kim SG (2005) Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1. Biochim Biophys Acta 1744:47–57. doi:10.1016/j.bbamcr.2004.11.004 Cho MK, Suh SH, Lee CH, Kim SG (2005) Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1. Biochim Biophys Acta 1744:47–57. doi:10.​1016/​j.​bbamcr.​2004.​11.​004
12.
go back to reference Klekotka PA, Santoro SA, Ho A, Dowdy SF, Zutter MM (2001) Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol 159:983–992PubMedCrossRef Klekotka PA, Santoro SA, Ho A, Dowdy SF, Zutter MM (2001) Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol 159:983–992PubMedCrossRef
13.
go back to reference Gudjonsson T, Ronnov-Jessen L, Villadsen R, Bissell MJ, Petersen OW (2003) To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia. Methods 30:247–255PubMedCrossRef Gudjonsson T, Ronnov-Jessen L, Villadsen R, Bissell MJ, Petersen OW (2003) To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia. Methods 30:247–255PubMedCrossRef
14.
go back to reference Ronnov-Jessen L, Bissell MJ (2009) Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med 15:5–13PubMedCrossRef Ronnov-Jessen L, Bissell MJ (2009) Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med 15:5–13PubMedCrossRef
15.
16.
go back to reference Wozniak MA, Keely PJ (2005) Use of three-dimensional collagen gels to study mechanotransduction in T47D breast epithelial cells. Biol Proced Online 7:144–161PubMedCrossRef Wozniak MA, Keely PJ (2005) Use of three-dimensional collagen gels to study mechanotransduction in T47D breast epithelial cells. Biol Proced Online 7:144–161PubMedCrossRef
17.
go back to reference Guo X, Hartley RS (2006) HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res 66:7948–7956PubMedCrossRef Guo X, Hartley RS (2006) HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res 66:7948–7956PubMedCrossRef
18.
go back to reference Hall DE, Reichardt LF, Crowley E, Holley B, Moezzi H, Sonnenberg A, Damsky CH (1990) The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J Cell Biol 110:2175–2184PubMedCrossRef Hall DE, Reichardt LF, Crowley E, Holley B, Moezzi H, Sonnenberg A, Damsky CH (1990) The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J Cell Biol 110:2175–2184PubMedCrossRef
19.
go back to reference Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ (2006) Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 66:1526–1535PubMedCrossRef Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ (2006) Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 66:1526–1535PubMedCrossRef
20.
go back to reference Porter DC, Keyomarsi K (2000) Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Res 28:E101PubMedCrossRef Porter DC, Keyomarsi K (2000) Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Res 28:E101PubMedCrossRef
21.
go back to reference Harwell RM, Porter DC, Danes C, Keyomarsi K (2000) Processing of cyclin E differs between normal and tumor breast cells. Cancer Res 60:481–489PubMed Harwell RM, Porter DC, Danes C, Keyomarsi K (2000) Processing of cyclin E differs between normal and tumor breast cells. Cancer Res 60:481–489PubMed
22.
go back to reference Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226–231PubMed Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226–231PubMed
23.
go back to reference Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278:30339–30347PubMedCrossRef Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278:30339–30347PubMedCrossRef
24.
go back to reference Gladden AB, Diehl JA (2005) Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 96:906–913PubMedCrossRef Gladden AB, Diehl JA (2005) Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 96:906–913PubMedCrossRef
25.
go back to reference Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753–761PubMed Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753–761PubMed
26.
go back to reference Benaud CM, Dickson RB (2001) Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Oncogene 20:4554–4567PubMedCrossRef Benaud CM, Dickson RB (2001) Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Oncogene 20:4554–4567PubMedCrossRef
27.
go back to reference Guo X, Wu Y, Hartley RS (2009) Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer. Mol Carcinog 49(2):130–140 Guo X, Wu Y, Hartley RS (2009) Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer. Mol Carcinog 49(2):130–140
28.
go back to reference Aoki K, Matsumoto K, Tsujimoto M (2003) Xenopus cold-inducible RNA-binding protein 2 interacts with ElrA, the Xenopus homolog of HuR, and inhibits deadenylation of specific mRNAs. J Biol Chem 278:48491–48497PubMedCrossRef Aoki K, Matsumoto K, Tsujimoto M (2003) Xenopus cold-inducible RNA-binding protein 2 interacts with ElrA, the Xenopus homolog of HuR, and inhibits deadenylation of specific mRNAs. J Biol Chem 278:48491–48497PubMedCrossRef
30.
go back to reference De Leeuw F, Zhang T, Wauquier C, Huez G, Kruys V, Gueydan C (2007) The cold-inducible RNA-binding protein migrates from the nucleus to cytoplasmic stress granules by a methylation-dependent mechanism and acts as a translational repressor. Exp Cell Res 313:4130–4144PubMedCrossRef De Leeuw F, Zhang T, Wauquier C, Huez G, Kruys V, Gueydan C (2007) The cold-inducible RNA-binding protein migrates from the nucleus to cytoplasmic stress granules by a methylation-dependent mechanism and acts as a translational repressor. Exp Cell Res 313:4130–4144PubMedCrossRef
31.
go back to reference Nishiyama H, Itoh K, Kaneko Y, Kishishita M, Yoshida O, Fujita J (1997) A glycine-rich RNA-binding protein mediating cold-inducible suppression of mammalian cell growth. J Cell Biol 137:899–908PubMedCrossRef Nishiyama H, Itoh K, Kaneko Y, Kishishita M, Yoshida O, Fujita J (1997) A glycine-rich RNA-binding protein mediating cold-inducible suppression of mammalian cell growth. J Cell Biol 137:899–908PubMedCrossRef
32.
go back to reference McCall-Culbreath KD, Zutter MM (2008) Collagen receptor integrins: rising to the challenge. Current Drug Targets 9:139–149PubMedCrossRef McCall-Culbreath KD, Zutter MM (2008) Collagen receptor integrins: rising to the challenge. Current Drug Targets 9:139–149PubMedCrossRef
34.
go back to reference White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ (2004) Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159–170. doi:10.1016/j.ccr.2004.06.025 PubMedCrossRef White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ (2004) Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159–170. doi:10.​1016/​j.​ccr.​2004.​06.​025 PubMedCrossRef
36.
go back to reference Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ (1998) Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95:14821–14826PubMedCrossRef Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ (1998) Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95:14821–14826PubMedCrossRef
37.
go back to reference Pasqualini R, Hemler ME (1994) Contrasting roles for integrin beta 1 and beta 5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration. J Cell Biol 125:447–460PubMedCrossRef Pasqualini R, Hemler ME (1994) Contrasting roles for integrin beta 1 and beta 5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration. J Cell Biol 125:447–460PubMedCrossRef
38.
go back to reference Benaud CM, Dickson RB (2001) Regulation of the expression of c-Myc by beta1 integrins in epithelial cells. Oncogene 20:759–768PubMedCrossRef Benaud CM, Dickson RB (2001) Regulation of the expression of c-Myc by beta1 integrins in epithelial cells. Oncogene 20:759–768PubMedCrossRef
39.
go back to reference Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231–245PubMedCrossRef Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231–245PubMedCrossRef
40.
go back to reference Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS (2002) The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111:29–40PubMedCrossRef Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS (2002) The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111:29–40PubMedCrossRef
41.
go back to reference Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ (2003) ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 163:583–595. doi:10.1083/jcb.200305010 PubMedCrossRef Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ (2003) ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 163:583–595. doi:10.​1083/​jcb.​200305010 PubMedCrossRef
42.
go back to reference Tsuboi N, Yoshida H, Kawamura T, Furukawa Y, Hosoya T, Yamada H (2000) Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells. Kidney Int 57:1581–1589PubMedCrossRef Tsuboi N, Yoshida H, Kawamura T, Furukawa Y, Hosoya T, Yamada H (2000) Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells. Kidney Int 57:1581–1589PubMedCrossRef
44.
go back to reference Pontano LL, Diehl JA (2008) Speeding through cell cycle roadblocks: nuclear cyclin D1-dependent kinase and neoplastic transformation. Cell Div 3:12PubMedCrossRef Pontano LL, Diehl JA (2008) Speeding through cell cycle roadblocks: nuclear cyclin D1-dependent kinase and neoplastic transformation. Cell Div 3:12PubMedCrossRef
45.
go back to reference Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H, Lu F, Rustgi AK, Diehl JA (2008) Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14:68–78PubMedCrossRef Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H, Lu F, Rustgi AK, Diehl JA (2008) Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14:68–78PubMedCrossRef
46.
go back to reference Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA (2008) Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 27:1231–1242PubMedCrossRef Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA (2008) Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 27:1231–1242PubMedCrossRef
47.
go back to reference Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59:423–450PubMed Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59:423–450PubMed
Metadata
Title
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells
Authors
Yuehan Wu
Xun Guo
Yekaterina Brandt
Helen J. Hathaway
Rebecca S. Hartley
Publication date
01-06-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1013-x

Other articles of this Issue 2/2011

Breast Cancer Research and Treatment 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine